ASTRIDE trial got bad results with 0 asiatics. DeLLphi-305 got great results with ~40% of Asiatic people and only ~10% of “Americas” people, despite of a big number of 🏥 were opened in the trial. Things turn out for a reason…. #Think #SCLC #ESMO26 https://oncodaily.com/oncolibrary/lung-oncology/astride-esmo26